John C Lieske1. 1. Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Abstract
BACKGROUND: Urinary supersaturation is one key determinant of calcium oxalate (CaOx) urinary stone formation, and urinary excretions of oxalate and citrate are two key determinants. Each is influenced by gastrointestinal processes. METHODS: Open label and randomized placebo studies have examined the effect of oral probiotic preparations on urinary supersaturation and oxalate excretion. Cross sectional studies in humans have studied the association of Oxalobacter formigenes colonization status and urinary oxalate excretion and prevalence of urinary stones. The intestinal microbiome of representative animals adapted to a high oxalate diet has been defined. RESULTS: The fecal content of O. formigenes, the best studied oxalate-degrader, varies depending on stone status. However, trials with probiotics designed to degrade oxalate including those containing O. formigenes, Lactobacillus, and/or Bifidobacterium spp., have been disappointing. Multiple intestinal segments of animals on a high oxalate diet contains diverse communities of microorganisms that can function together to degrade and detoxify a large oxalate load. CONCLUSIONS: Although the intestinal microbiome seems likely to play a role to modify gastrointestinal absorption of lithogenic substances and hence urinary stone risk, whether we can develop tools to manipulate it and decrease this kidney stone risk remains to be determined.
BACKGROUND: Urinary supersaturation is one key determinant of calcium oxalate (CaOx) urinary stone formation, and urinary excretions of oxalate and citrate are two key determinants. Each is influenced by gastrointestinal processes. METHODS: Open label and randomized placebo studies have examined the effect of oral probiotic preparations on urinary supersaturation and oxalate excretion. Cross sectional studies in humans have studied the association of Oxalobacter formigenes colonization status and urinary oxalate excretion and prevalence of urinary stones. The intestinal microbiome of representative animals adapted to a high oxalate diet has been defined. RESULTS: The fecal content of O. formigenes, the best studied oxalate-degrader, varies depending on stone status. However, trials with probiotics designed to degrade oxalate including those containing O. formigenes, Lactobacillus, and/or Bifidobacterium spp., have been disappointing. Multiple intestinal segments of animals on a high oxalate diet contains diverse communities of microorganisms that can function together to degrade and detoxify a large oxalate load. CONCLUSIONS: Although the intestinal microbiome seems likely to play a role to modify gastrointestinal absorption of lithogenic substances and hence urinary stone risk, whether we can develop tools to manipulate it and decrease this kidney stone risk remains to be determined.
Authors: John C Lieske; William J Tremaine; Claudio De Simone; Helen M O'Connor; Xujian Li; Eric J Bergstralh; David S Goldfarb Journal: Kidney Int Date: 2010-08-25 Impact factor: 10.612
Authors: John C Lieske; Andrew D Rule; Amy E Krambeck; James C Williams; Eric J Bergstralh; Ramila A Mehta; Thomas P Moyer Journal: Clin J Am Soc Nephrol Date: 2014-10-02 Impact factor: 8.237
Authors: Zhirong Jiang; John R Asplin; Andrew P Evan; Vazhaikkurichi M Rajendran; Heino Velazquez; Timothy P Nottoli; Henry J Binder; Peter S Aronson Journal: Nat Genet Date: 2006-03-12 Impact factor: 38.330
Authors: Andrew P Evan; James E Lingeman; Fredric L Coe; Sharon B Bledsoe; Andre J Sommer; James C Williams; Amy E Krambeck; Elaine M Worcester Journal: Kidney Int Date: 2009-08-26 Impact factor: 10.612
Authors: Andrew P Evan; Fredric L Coe; James E Lingeman; Youzhi Shao; Andre J Sommer; Sharon B Bledsoe; Jennifer C Anderson; Elaine M Worcester Journal: Anat Rec (Hoboken) Date: 2007-10 Impact factor: 2.064
Authors: David W Kaufman; Judith P Kelly; Gary C Curhan; Theresa E Anderson; Stephen P Dretler; Glenn M Preminger; David R Cave Journal: J Am Soc Nephrol Date: 2008-03-05 Impact factor: 10.121
Authors: Matthew R D'Costa; Annamaria T Kausz; Kevin J Carroll; Jóhann P Ingimarsson; Felicity T Enders; Kristin C Mara; Ramila A Mehta; John C Lieske Journal: Nephrol Dial Transplant Date: 2021-12-02 Impact factor: 5.992
Authors: Xiangling Wang; Gauri Bhutani; Lisa E Vaughan; Felicity T Enders; Zejfa Haskic; Dawn Milliner; John C Lieske Journal: BMC Nephrol Date: 2020-04-15 Impact factor: 2.388